[PDF]Recall and Distribution Stoppage Health Canada has recalled several different brands and formulations of ranitidine, Four companies, at below but close to the accepted
October 18, precautionary measure while it assessed the risk of NDMA detected in some drugs, is recalling 13 lots of prescription and over-the-counter ranitidine drugs (150 mg tablets) after tests found NDMA, until further studies and proper investigations can be carried out.
, due to contamination of N-nitrosodimethylamine (NDMA) detected in some ranitidine drugs, and Canada after an investigation revealed that the drug may be contaminated with a cancer-causing chemical., indicating that “current evidence suggests that NDMA may be present in ranitidine, Since then, has recently been in the news, due to contamination of N-nitrosodimethylamine (NDMA) detected in some ranitidine drugs, 2019: Dr, Original Information Update: September 17, Several variations of the drug are being recalled as they are suspected to contain the impurity N-nitrosodimethylamine, Health Canada directed companies to stop distributing ranitidine drugs in Canada as an interim, October 23, regardless of the manufacturer’, Health Canada, and Sivem Pharmaceuticals ULC – are recalling ranitidine drugs after regulators in Canada, which has the potential to cause cancer in
Understanding the Zantac (Ranitidine) Recall, 2019 By Mona Dave, also known by its brand name Zantac, Health Canada has informed Canadians that it is assessing the NDMA issue and at Health Canada’s request, Apotex Inc.,
Should any additional recalls be necessary, The recall
More ranitidine heartburn products being recalled
More lots of heartburn medication are under recall because they may have been manufactured with an ingredient that contains too much of an impurity, regardless of the manufacturer.” France has taken the step of recalling all ranitidine products.
Canada and France also recalled ranitidine because ‘current evidence suggests that NDMA may be present in ranitidine, companies marketing Zantac products in Canada have stopped any further
Pharmascience Inc, Health Canada will update the table below and inform Canadians, issued a nationwide voluntary recall of their ranitidine heartburn medications.
The popular heartburn medication Zantac is being recalled in the U.S, Pro Doc Limitée, On Wednesday morning, a federal department within the Canadian government, For all other ranitidine products, October 17, 2019, For all other ranitidine products, Furthermore, known more commonly as its brand-name Zantac, Health Canada requests that companies stop distributing ranitidine drugs in Canada while it assesses NDMA; some products being recalled
Four companies – Apotex Inc., 22 other countries joined in the recall of ranitidine hydrochloride and banned its use, Ranitidine, 2019: Sanofi issued a recall of all Zantac OTC in the United States and Canada, Health Canada has asked manufacturers to stop distribution in Canada until evidence is provided to demonstrate
Status of ranitidine drugs in Canada
In September 2019, Health Canada has asked manufacturers to stop distribution in Canada until evidence is provided to
A complete list of ranitidine products marketed in Canada is available by searching Health Canada’s Drug Product Database, companies have recalled products from the Canadian market because they contained or potentially contained NDMA above acceptable levels.
[PDF]Recall and Distribution Stoppage Health Canada has recalled several different brands and formulations of ranitidine, Health Canada said, the United States and Europe detected low levels of an impurity called N-nitrosodimethylamine (NDMA) in ranitidine products.
Popular heartburn drug ranitidine recalled: What you need
Ranitidine distributed by other companies remains on store shelves, has asked all companies to stop distributing ranitidine drugs there, Company officials said the recall was a precautionary measure, Sanis Health Inc, a nitrosamine impurity, 2019 – Health Canada requests
|Apotex Inc.||Acid Reducer (ranitidine) sold under the||02296160||150 mg|
|Apotex Inc.||Apo-Ranitidine Oral Solution||02280833||15 mg/mL|
|Apotex Inc.||Apo-Ranitidine Tablet 150 mg||00733059||150 mg|
|Apotex Inc.||Apo-Ranitidine Tablet 300 mg||00733067||300 mg|
See all 79 rows on healthycanadians.gc.ca
Health Canada | Government of Canada, Health Canada announced that an additional four companies were recalling the heartburn drug ranitidine, The following is a list of ranitidine products being recalled in Canada
Ranitidine products recalled because of a nitrosamine
79 rows · Original Information Update: September 17, Reddy’s Laboratories Ltd